Trial Profile
A Real-World Retrospective study to assess the treatment persistence of droxidopa in patients with Neurogenic Orthostatic Hypotension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2018
Price :
$35
*
At a glance
- Drugs Droxidopa (Primary)
- Indications Orthostatic hypotension
- Focus Adverse reactions; Therapeutic Use
- 10 May 2018 New trial record
- 05 May 2018 Results presented at the 2018 Annual Scientific Meeting of the American Geriatrics Society
- 27 Apr 2018 Results presented at the 70th Annual Meeting of the American Academy of Neurology